| Bioactivity | NSC 107512 is a potent inhibitor of cyclin-dependent kinase 9 (CDK9). NSC 107512 is a class of sangivamycin-like molecules (SLM). NSC 107512 inhibits growth and induces apoptosis of multiple myeloma tumors[1]. |
| Name | NSC 107512 |
| CAS | 22242-89-3 |
| Formula | C12H16N6O5 |
| Molar Mass | 324.29 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | -20°C, protect from light, stored under nitrogen *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen) |
NSC 107512
CAS: 22242-89-3 F: C12H16N6O5 W: 324.29
NSC 107512 is a potent inhibitor of cyclin-dependent kinase 9 (CDK9). NSC 107512 is a class of sangivamycin-like molecul
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.